Lisinopril HCTZ   3

Background
The Defense Logistics Agency (DLA) Troop Support, Directorate of Medical Materiel provides pharmaceutical products for the Department of Defense (DoD) to its customers through its Pharmaceutical Prime Vendor program. The Department of Veterans Affairs (VA) provides pharmaceutical products to its customers as well as the Indian Health Service (IHS) and the Bureau of Prisons (BoP) through the VA Pharmaceutical Prime Vendor Program. Hereafter these programs are collectively referred to as the “PPV.” A prime vendor is an independent business concern that functions as a purchaser's primary source for specified classes of products and is responsible for the delivery of goods produced by various suppliers. As a part of the Pharmaceutical Prime Vendor Program, this solicitation will establish a national contract for the items listed in the schedule. The PPV Programs consist of separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government (i.e., Federal Supply Schedules, DLA National Contracts) contracts. The awardee consents to allow VA and DLA Troop Support Prime Vendors to distribute the listed products in the schedule.

Work Details
Lisinopril HCTZ 20 – 12.5 MG Tablet – 90 Count*, Lisinopril HCTZ 20 – 12.5 MG Tablet – 100 Count, Lisinopril HCTZ 20 – 12.5 MG Tablet – 500 Count, Lisinopril HCTZ 20 – 12.5 MG Tablet – 1000 Count, Lisinopril HCTZ 20 – 25 MG Tablet – 90 Count*, Lisinopril HCTZ 20 – 25 MG Tablet – 100 Count, Lisinopril HCTZ 20 – 25 MG Tablet – 500 Count, Lisinopril HCTZ 20 – 25 MG Tablet – 1000 Count, Lisinopril HCTZ 10 – 12.5 MG Tablet – 90 Count*, Lisinopril HCTZ 10 – 12.5 MG Tablet – 100 Count, Lisinopril HCTZ 10 – 12.5 MG Tablet – 500 Count, Lisinopril HCTZ 10 – 12.5 MG Tablet – 1000 Count

Period of Performance
The Contract Price Effective Date shall be no more than 60 calendar days after award.